{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:59:24Z","timestamp":1791932364483,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019655","name":"ICW Healthcare Ventures","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI48793"],"award-info":[{"award-number":["R01 AI48793"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008169","name":"Minneapolis Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008169","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.heliyon.2022.e11676","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T11:38:04Z","timestamp":1668857884000},"page":"e11676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Longitudinal antibody titer, avidity, and neutralizing responses after SARS-CoV-2 infection"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2458-9182","authenticated-orcid":false,"given":"Jonathon M.","family":"Monroe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iana H.","family":"Haralambieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel D.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane E.","family":"Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy Quang","family":"Quach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6164-4967","authenticated-orcid":false,"given":"Richard B.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2022.e11676_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.07.012","article-title":"The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2022.e11676_bib2","article-title":"Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles","author":"Syed","year":"2022","journal-title":"medRxiv"},{"key":"10.1016\/j.heliyon.2022.e11676_bib3","unstructured":"Johns Hopkins University Coronavirus Resource Center World Map, https:\/\/coronavirus.jhu.edu\/map.html (last accessed Nov 13, 2022)."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11676_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/jiac042","article-title":"Distinct homologous and variant-specific memory B-cell and antibody response over time after SARS-CoV-2 mRNA vaccination","volume":"226","author":"Haralambieva","year":"2022","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.heliyon.2022.e11676_bib5","first-page":"371","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","author":"Dan","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2022.e11676_bib6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/s41591-021-01432-4","article-title":"A\u00a0correlate of protection for SARS-CoV-2 vaccines is urgently needed","volume":"27","author":"Krammer","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2022.e11676_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijid.2021.01.061","article-title":"The potential significance of high avidity immunoglobulin G (IgG) for protective immunity towards SARS-CoV-2","volume":"106","author":"Bauer","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.heliyon.2022.e11676_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.570018","article-title":"Blocking of the high-affinity interaction-synapse between SARS-CoV-2 spike and human ACE2 proteins likely requires multiple high-affinity antibodies: an immune perspective","volume":"11","author":"Khatri","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2022.e11676_bib9","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.immuni.2021.07.008","article-title":"Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations","volume":"54","author":"Muecksch","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.heliyon.2022.e11676_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41577-019-0244-2","article-title":"B\u00a0cell memory: building two walls of protection against pathogens","volume":"20","author":"Akkaya","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2022.e11676_bib11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cell.2019.03.016","article-title":"B\u00a0cell responses: cell interaction dynamics and decisions","volume":"177","author":"Cyster","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2022.e11676_bib12","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2022.e11676_bib13","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","article-title":"BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans","volume":"595","author":"Sahin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2022.e11676_bib14","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1016\/j.vaccine.2021.05.063","article-title":"Evidence for antibody as a protective correlate for COVID-19 vaccines","volume":"39","author":"Earle","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.heliyon.2022.e11676_bib15","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2022.e11676_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.37349\/ei.2022.00040","article-title":"High avidity of vaccine-induced immunoglobulin G against SARS-CoV-2: potential relevance for protective humoral immunity","volume":"2","author":"Bauer","year":"2022","journal-title":"Explor. Immonol."},{"key":"10.1016\/j.heliyon.2022.e11676_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-95045-z","article-title":"Assessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients","volume":"11","author":"Moura","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2022.e11676_bib18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/v14030617","article-title":"Avidity of IgG to SARS-CoV-2 RBD as a prognostic factor for the severity of COVID-19 reinfection","volume":"14","author":"Manuylov","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.heliyon.2022.e11676_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf2467","article-title":"Longitudinal antibody repertoire in \u201cmild\u201d versus \u201csevere\u201d COVID-19 patients reveals immune markers associated with disease severity and resolution","volume":"7","author":"Ravichandran","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.heliyon.2022.e11676_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-21463-2","article-title":"Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients","volume":"12","author":"Tang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2022.e11676_bib21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.chom.2020.06.021","article-title":"Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2","volume":"28","author":"Case","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.heliyon.2022.e11676_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12250-020-00230-5","article-title":"On the calculation of TCID(50) for quantitation of virus infectivity","volume":"36","author":"Lei","year":"2021","journal-title":"Virol. Sin."},{"key":"10.1016\/j.heliyon.2022.e11676_bib23","article-title":"Fitting linear mixed-effects models using lme 4","author":"Bates","year":"2014","journal-title":"arXiv"},{"key":"10.1016\/j.heliyon.2022.e11676_bib24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3389\/fpsyg.2017.00456","article-title":"Repeated measures correlation","volume":"8","author":"Bakdash","year":"2017","journal-title":"Front. Psychol."},{"key":"10.1016\/j.heliyon.2022.e11676_bib25","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2022.e11676_bib26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","article-title":"Sex differences in immune responses that underlie COVID-19 disease outcomes","volume":"588","author":"Takahashi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2022.e11676_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4049\/jimmunol.2000898","article-title":"SARS-CoV-2 antibody responses are correlated to disease severity in COVID-19 convalescent individuals","volume":"206","author":"Hansen","year":"2021","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.heliyon.2022.e11676_bib28","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","article-title":"Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity","volume":"183","author":"Rydyznski Moderbacher","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2022.e11676_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbrc.2020.10.060","article-title":"T\u00a0cell immunity to SARS-CoV-2 following natural infection and vaccination","volume":"538","author":"DiPiazza","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.heliyon.2022.e11676_bib30","article-title":"Robust T cell response toward spike, Membrane, and nucleocapsid SARS-CoV-2 proteins is not associated with recovery in critical COVID-19 patients","volume":"1","author":"Thieme","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.heliyon.2022.e11676_bib31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2022.e11676_bib32","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1002\/jmv.27270","article-title":"Vaccination versus infection with SARS-CoV-2: establishment of a high avidity IgG response versus incomplete avidity maturation","volume":"93","author":"Struck","year":"2021","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.heliyon.2022.e11676_bib33","article-title":"The Plasmablast Response to SARS-CoV-2 mRNA Vaccination Is Dominated by Non-neutralizing Antibodies and Targets Both the NTD and the RBD","author":"Amanat","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.heliyon.2022.e11676_bib34","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/prot.26086","article-title":"Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor","volume":"89","author":"Delgado","year":"2021","journal-title":"Proteins"},{"key":"10.1016\/j.heliyon.2022.e11676_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2022.e11676_bib36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41586-021-04060-7","article-title":"Anti-SARS-CoV-2 receptor-binding domain\u00a0antibody evolution after mRNA vaccination","volume":"600","author":"Cho","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2022.e11676_bib37","article-title":"Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19","volume":"2","author":"Harrington","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.heliyon.2022.e11676_bib38","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","article-title":"Evolution of antibody immunity to SARS-CoV-2","volume":"591","author":"Gaebler","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2022.e11676_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2021.104986","article-title":"Dynamics of IgG-avidity and antibody levels after covid-19","volume":"144","author":"L\u00f6fstr\u00f6m","year":"2021","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.heliyon.2022.e11676_bib40","doi-asserted-by":"crossref","first-page":"e3095","DOI":"10.1093\/cid\/ciaa1389","article-title":"Kinetics of severe acute\u00a0respiratory syndrome Coronavirus 2 (SARS-CoV-2) antibody avidity maturation and association with disease severity","volume":"73","author":"Luo","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2022.e11676_bib41","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/infdis\/jiab300","article-title":"Marked increase in avidity of SARS-CoV-2 antibodies 7-8 Months after infection is not diminished in old age","volume":"224","author":"Pichler","year":"2021","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.heliyon.2022.e11676_bib42","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1038\/s41467-021-26479-2","article-title":"Anti-spike antibody response to natural SARS-CoV-2 infection in the general population","volume":"12","author":"Wei","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2022.e11676_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.heliyon.2022.e11676_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.655896","article-title":"IgA antibodies and IgA deficiency in SARS-CoV-2 infection","volume":"11","author":"Quinti","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022029644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022029644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:57:40Z","timestamp":1775606260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844022029644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2405844022029644"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11676","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal antibody titer, avidity, and neutralizing responses after SARS-CoV-2 infection","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11676","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e11676"}}